Suri, Amreena; Bailey, Anders W.; Tavares, Maurício Temotheo 
; Gunosewoyo, Hendra; Dyer, Connor P.; Grupenmacher, Alex T.; Piper, David R.; Horton, Robert A.; Tomita, Tadanori; Kozikowski, Alan P.; Roy, Saktimayee M.; Sredni, Simone T.
Source: International Journal of Molecular Sciences. Unidade: FCF
Subjects: MEDULOBLASTOMA, PROTEÍNAS QUINASES, CARCINOGÊNESE, NEOPLASIAS CEREBRAIS, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SURI, Amreena et al. Evaluation of protein kinase inhibitors with PLK4 cross-over potential in a pre-clinical model of cancer. International Journal of Molecular Sciences, v. 20, n. 9, p. [22] , 2019Tradução . . Disponível em: https://doi.org/10.3390/ijms20092112. Acesso em: 18 nov. 2024.APA
Suri, A., Bailey, A. W., Tavares, M. T., Gunosewoyo, H., Dyer, C. P., Grupenmacher, A. T., et al. (2019). Evaluation of protein kinase inhibitors with PLK4 cross-over potential in a pre-clinical model of cancer. International Journal of Molecular Sciences, 20( 9), [22] . doi:10.3390/ijms20092112NLM
Suri A, Bailey AW, Tavares MT, Gunosewoyo H, Dyer CP, Grupenmacher AT, Piper DR, Horton RA, Tomita T, Kozikowski AP, Roy SM, Sredni ST. Evaluation of protein kinase inhibitors with PLK4 cross-over potential in a pre-clinical model of cancer [Internet]. International Journal of Molecular Sciences. 2019 ; 20( 9): [22] .[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ijms20092112Vancouver
Suri A, Bailey AW, Tavares MT, Gunosewoyo H, Dyer CP, Grupenmacher AT, Piper DR, Horton RA, Tomita T, Kozikowski AP, Roy SM, Sredni ST. Evaluation of protein kinase inhibitors with PLK4 cross-over potential in a pre-clinical model of cancer [Internet]. International Journal of Molecular Sciences. 2019 ; 20( 9): [22] .[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ijms20092112
